Skin Cancer Dermatology Market - Forecast(2022 - 2027)

Report Code: HCR 1404 Report Format: PDF + Excel

Skin Cancer Dermatology Market Overview

Skin Cancer Dermatology Market size is projected to reach $2,020.3 million by 2026, growing at a CAGR of 5.4% over 2021-2026. Skin cancer is considered as the most dangerous disease that grows continuously in the epidermis which is the outer skin layer. Basal cell carcinoma and merkel cell carcinoma are the most common types of Skin cancer. Skin cancer is mainly caused due to harmful ultraviolet rays of sun and the use of UV tanning beds. People who are suffering from poor pigmentation have more chances of skin cancer. Skin cancer is growing like abnormal cells and about 80% of skin cancer develops from basal cell carcinoma. Radiation therapy and diagnostic imaging are mostly used to kill the cancer cells by focusing outside the body of tumor. Skin cancer can also be destroyed by using cryosurgery which is safe, low cost and effective treatment that produce excellent results with a high cure rate. The purpose of dermatoscopy is to improve the detection of skin cancer cells which are mostly used by dermatologists. Skin cancer is also increasing owing to weak immunity system among people. Rising awareness about the skin cancer among people and growing advancement of technology in dermatology sector is the major factor driving the growth of Skin Cancer Dermatology Market. Furthermore, changing lifestyle of consumers and rising development and research in the healthcare industry is set to further enhance the overall market demand for Skin Cancer Dermatology Market for the period 2021-2026. 

Report Coverage

The report: “Skin Cancer Dermatology Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Skin Cancer Dermatology Market.    
By Test Type: Dermatoscopy, Skin Biopsy, Diagnostic Imaging, and Others 
By Age Group: 0-19, 20-39, 40-59, 60-64, and Others
By Facility Type: Hospital OPD, Dermatology Group, Stand-alone, Multispecialty Clinics, and Others
By Geography: North America (U.S., Canada, Mexico), Europe (U.K, Germany, Italy, France, Spain, Russia, Rest of Europe), Asia Pacific (China, Australia, Japan, South Korea, India, Rest of Asia Pacific), South America (Brazil, Argentina, Others) and Rest of the World (Middle East, Africa)

Key Takeaways

  • In 2020, North America dominated the Skin Cancer Market owing to the growing prevalence of skin cancer that is rising the demand of skin dermatology. Moreover, growing adoption of various technologies in healthcare sector is rising the growth in the treatment of skin cancer diseases which in turn is driving the market growth of Skin Cancer Dermatology.
  • Rising awareness about the skin cancer among people and growing advancement of technology in dermatology sector are enhancing the growth of the Skin Cancer Dermatology Market. 
  • The prominent manufacturers operating in the market will be provided detailed analysis of Strength, Weakness, and Opportunities in the Skin Cancer Dermatology Market report.  
  • High cost of Treatment is set to create hurdles for the Skin Cancer Dermatology Market. 

Skin Care Dermatology Market Size, By Facility Type 2020-2026 (USD Million)
 
For more details on this report - Request for Sample

Skin Cancer Dermatology Market Segment Analysis – By Test Type

The Skin Cancer Dermatology Market based on Test Type can be further distributed into Dermatoscopy, Skin Biopsy, Diagnostic Imaging, and Others. The Skin Biopsy segment is the major segment generating revenue in 2020. This is mainly owing to the fact that skin biopsy is used in different types of skin conditions that include infections, melanoma and many more which is rising the adoption of skin biopsy among dermatologist. Moreover, it provides effective results of reducing infections on skin that further propells the market growth. The Diagnostic Imaging segment is estimated to register the fastest CAGR of 5.9% for the period 2021-2026. This is mainly owing to the fact that diagnostic imaging provides clear image of disease that helps dermatologist to identify the type of skin cancer which helps to provide accurate treatment of particular skin cancer which further propelling the growth of Skin Cancer Dermatology Market. 

Skin Cancer Dermatology Market Segment Analysis – By Facility Type

The Skin Care Dermatology Market based on Facility Type can be further segmented into Hospital OPD, Dermatology Group, Stand-alone, Multispecialty Clinics, and Others. The Hospital OPD segment registers for the highest Skin Care Dermatology Market share in 2020. This is mainly owing to the availability of variety of technologies that are used for treating skin cancer and rising availability of skilled professional in hospital to help patients to treat accurately according to the type of skin diseases. Moreover, rising facility of ambulances in hospitals helps patients to visit hospital at accurate time that rising the growth of Skin Care Dermatology market. The Dermatology Group segment is forecasted to register the fastest CAGR of 6.1% over 2021-2026. This is mainly owing to rising presence of dermatology specialist that helps patient to treat accordingly. Moreover, dermatology group provide treatment to patient in full fledge as they are dealing with the skin only which in turn enhancing the growth of Skin Care Dermatology Market.

Skin Cancer Dermatology Market Segment Analysis – By Geography

North America dominated the Skin Care Dermatology Market with major share of 45% in 2020. This is owing to growing prevalence of skin cancer that is rising the demand of skin dermatology. Moreover, growing adoption of various technology in healthcare sector rising the growth in the treatment of skin cancer diseases which in turn driving the market growth of Skin Cancer Dermatology. The American Academy of Dermatology are also focusing on enhancing the activities in research in dermatology sector that helps to prevent from skin cancer. 

However, Asia Pacific is projected to be the growing market during the forecast period 2021-2026 owing to the growing adoption of advanced technologies for the treatment of skin cancer and growing development of healthcare infrastructure which is rising the adoption of dermatology treatment in hospitals. In China and India, prevalence of skin cancer is rising owing to the harmful radiation of sun and this is further enhancing the market growth. 

Skin Cancer Dermatology Market Drivers

Growing Prevalence of Skin Cancer Disease

Skin cancer is the most common types of cancer among population that is rising the demand of skin cancer treatment and thus enhancing the market growth. According to American Academy of Dermatology Association, about 1 million people are suffering from melanoma skin cancer and more than 9,500 people in U.S. are diagnosed with skin cancer daily that further rising the growth of the Skin Cancer Dermatology Market over the period 2021-2026.

Growing Advancement of Technology in the Dermatology Sector

The rising adoption of modern technology and devices in dermatology sector helps to improve the treatment of skin cancer. Moreover, rising innovation in smartphone compatible diagnostics devices helps dermatologist to diagnose patients remotely and growing adoption of electric health record technology enable dermatologist to provide treatment at low cost which in turn boosting the growth of Skin Care Dermatology Market over the period 2021-2026.  

Covid Impact:    

COVID-19 pandemic had greatly impacted the growth of Skin Cancer Market. During pandemic, healthcare sector are engaged in treating the patients who are suffering from COVID-19 infections. So, they are not able to focus on the patients with skin cancer which are negatively impacted the growth of Skin Cancer Dermatology Market.   

Skin Cancer Dermatology Market Challenges 

High Cost of Treatment

The factors that is set to impede the growth of the Skin Care Dermatology Market are rising cost of treating skin cancer diseases as variety of technology are used to treat skin cancer that are costly which is set to restrain the growth of Skin Care Dermatology Market.

Skin Cancer Dermatology Market Landscape

Product launches, acquisitions, collaboration, joint ventures, and geographical expansions are key strategies adopted by players in the Skin Care Dermatology Market. Skin Care Dermatology top 10 companies are Firefly, SkinIO, 3Gen, Canfield, Fotofinder, MetaOptima, Agilent Technologies, Skin Analytics, Skin Vision, and Speclipse.

Skin Cancer Dermatology Market Development

  • In 2019, the U.S. Food and Drug Administration approved Pembrolizumab for the treatment of skin cancer disease.

Relevant Reports: 

Cancer Testing/Screening Market
Report Code: HCR 0078



For more Lifesciences and Healthcare related reports, please click here
1. Skin Cancer Dermatology Market Overview
    1.1 Definitions and Scope
2. Skin Cancer Dermatology Market Executive Summary
    2.1 Market Size and Key Trends
    2.2 Key trends by Test Type
    2.3 Key trends by Age Group
    2.4 Key trends by Facility Type
    2.5 Key trends by Geography
3. Skin Cancer Dermatology Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Skin Cancer Dermatology Market- Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Skin Cancer Dermatology Market- Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Skin Cancer Dermatology Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes
7. Skin Cancer Dermatology Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Skin Cancer Dermatology Market– By Test Type (Market Size -$Million/$Billion)
    8.1 Dermatoscopy
    8.2 Skin Biopsy
    8.3 Diagnostic Imaging
    8.4 Others
9. Skin Cancer Dermatology Market– By Age Group (Market Size -$Million/$Billion)
    9.1 0-19
    9.2 20-39
    9.3 40-59
    9.4 60-64
    9.5 Others
10. Skin Cancer Dermatology Market– By Facility Type (Market Size -$Million/$Billion)
    10.1 Hospital OPD
    10.2 Dermatology Group
    10.3 Stand-alone
    10.4 Multispecialty Clinics
    10.5 Others
11. Skin Cancer Dermatology Market- By Geography (Market Size -$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 Italy
        11.2.4 France
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Australia
        11.3.3 Japan
        11.3.4 South KoreaText Box: 06
        11.3.5 India
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Others
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Skin Cancer Dermatology Market Entropy
13. Skin Cancer Dermatology Market- Industry / Segment Competition landscape Premium Premium
    13.1 Market Share Analysis
        13.1.1 Market Share by Country- Key companies
        13.1.2 Market Share by Region- Key companies
        13.1.3 Market Share at Global Level- Key companies
        13.1.4 Competition Matrix
        13.1.5 Best Practices for Companies
14. Skin Cancer Dermatology Market- Key Company List by Country Premium Premium
15. Skin Cancer Dermatology Market Company Analysis
    15.1 Company Revenue, Products, M&A, Developments
    15.2 Company 1
    15.3 Company 2
    15.4 Company 3
    15.5 Company 4
    15.6 Company 5
    15.7 Company 6
    15.8 Company 7
    15.9 Company 8
    15.10 Company 9
    15.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.